Cardiol Therapeutics Inc. Class A Common Shares
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Open CRDL dashboard ↗Village Farms International, Inc. Common Shares
Village Farms International, Inc., together with its subsidiaries, produces, markets, and distributes greenhouse grown tomatoes, bell peppers, cucumbers, and mini-cukes in North America. It operates in five segments: Produce, Cannabis-Canada, Cannabis-U.S., Energy, and Leli. It produces and supplies cannabis products to other licensed providers and provincial governments in Canada and internationally; develops and sells cannabinoid-based health and wellness products, including ingestible, edibles, and topical applications; and produces power. The company also markets and distributes its products under the Village Farms brand name to retail supermarkets and fresh food distribution companies, as well as tomatoes, peppers and cucumbers produced under exclusive and non-exclusive arrangements from greenhouse supply partners. In addition, it produces and supplies cannabis products to designated coffee shops. The company was formerly known as Village Farms Canada Inc. and changed its name to Village Farms International, Inc. in December 2009. Village Farms International, Inc. was founded in 1989 and is headquartered in Lake Mary, Florida.
Open VFF dashboard ↗